DJ Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slipped 2.30% to $313.85 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.09% to 6,840.51 and Dow Jones Industrial Average falling 0.38% to 47,560.29.
This was the stock's fourth consecutive day of losses.
Amgen Inc. closed 9.39% short of its 52-week high of $346.38, which the company achieved on December 3rd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.82% to $199.96, Pfizer Inc. $(PFE)$ fell 1.71% to $25.33, and AbbVie Inc. $(ABBV)$ fell 0.06% to $222.99.
Trading volume (2.9 M) eclipsed its 50-day average volume of 2.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 09, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments